The safety and efficacy of immune-checkpoint inhibitors in patients with cancer and pre-existing autoimmune diseases
出版年份 2021 全文链接
标题
The safety and efficacy of immune-checkpoint inhibitors in patients with cancer and pre-existing autoimmune diseases
作者
关键词
-
出版物
Immunotherapy
Volume 13, Issue 6, Pages 527-539
出版商
Future Medicine Ltd
发表日期
2021-03-15
DOI
10.2217/imt-2020-0230
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Safe Use of Nivolumab in a Patient with Epipharyngeal Carcinoma and Preexisting Ulcerative Colitis: A Histologically Proven Case Report
- (2020) Yasuki Hijikata et al. INTERNAL MEDICINE
- Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies
- (2019) Christopher C. Frohne et al. Journal for ImmunoTherapy of Cancer
- Clinical Outcomes of Patients with Advanced Cancer and Pre‐Existing Autoimmune Diseases Treated with Anti‐Programmed Death‐1 Immunotherapy: A Real‐World Transverse Study
- (2019) Alessio Cortellini et al. ONCOLOGIST
- Immune checkpoint inhibitor use in antisynthetase syndrome
- (2019) David Mackintosh et al. Asia-Pacific Journal of Clinical Oncology
- Association of Checkpoint Inhibitor–Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non–Small Cell Lung Cancer
- (2019) Fiamma Berner et al. JAMA Oncology
- Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?
- (2019) Anne Zaremba et al. Journal for ImmunoTherapy of Cancer
- Nivolumab treatment in advanced lung cancer patient with chronic active hepatitis C and systemic lupus erythematosus
- (2019) Marco Tagliamento et al. Immunotherapy
- Immunotherapy-induced severe neutropenia with neurotoxicity: A case of a 75-year-old woman with ulcerative colitis diagnosed with melanoma
- (2019) Rima Patel et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Preexisting Autoimmune Disease: A Nationwide Multicenter Cohort Study
- (2019) Alice Tison et al. Arthritis & Rheumatology
- Non-small Cell Lung Cancer Treated by an Anti-programmed Cell Death-1 Antibody without a Flare-up of Preexisting Granulomatosis with Polyangiitis
- (2019) Takahiro Yamada et al. INTERNAL MEDICINE
- Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
- (2019) Satya Das et al. Journal for ImmunoTherapy of Cancer
- Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders
- (2018) Katharina C. Kähler et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease
- (2018) François-Xavier Danlos et al. EUROPEAN JOURNAL OF CANCER
- Exacerbation of autoimmune hemolytic anemia induced by the first dose of programmed death-1 inhibitor pembrolizumab: a case report
- (2018) Kenta Ogawa et al. INVESTIGATIONAL NEW DRUGS
- Safety of Programmed Death–1 Pathway Inhibitors Among Patients With Non–Small-Cell Lung Cancer and Preexisting Autoimmune Disorders
- (2018) Giulia C. Leonardi et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute Flare of Bullous Pemphigus With Pembrolizumab Used for Treatment of Metastatic Urothelial Cancer
- (2018) Rohan Garje et al. JOURNAL OF IMMUNOTHERAPY
- Ipilimumab treatment associated with myasthenic crises and unfavorable disease course
- (2018) Eda Derle et al. NEUROLOGICAL SCIENCES
- Painless Thyroiditis and Fulminant Type 1 Diabetes Mellitus in a Patient Treated with an Immune Checkpoint Inhibitor, Nivolumab
- (2018) Kanako Sakurai et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Brief Report: Cancer Immunotherapy in Patients With Preexisting Rheumatic Disease: The Mayo Clinic Experience
- (2018) Michael D. Richter et al. Arthritis & Rheumatology
- Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non–Small-Cell Lung Cancer
- (2018) Koji Haratani et al. JAMA Oncology
- Mécanismes physiopathologiques des effets secondaires des immunothérapies par anticorps anti-CTLA-4, anti-PD-1 et anti-PD-L1 dans le traitement du cancer
- (2018) Tilda Passat et al. BULLETIN DU CANCER
- Pembrolizumab for the first-line treatment of non-small cell lung cancer
- (2018) Kiichiro Ninomiya et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- PD-1 Inhibitor Immune-Related Adverse Events in Patients with Preexisting Endocrine Autoimmunity
- (2018) Halis Kaan Akturk et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non–Small-Cell Lung Cancer
- (2018) Kathryn C. Arbour et al. JOURNAL OF CLINICAL ONCOLOGY
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- Rapid Development of Graves’ Ophthalmopathy After Treatment With Ipilimumab and Recurrence With Pembrolizumab in a Patient With Previously Treated Graves’ Disease
- (2018) Logan Rhea et al. Journal of Oncology Practice
- Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity
- (2017) Ralf Gutzmer et al. EUROPEAN JOURNAL OF CANCER
- Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma
- (2017) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- The safety of pembrolizumab in metastatic melanoma and rheumatoid arthritis
- (2017) Akshjot Puri et al. MELANOMA RESEARCH
- Reversal of Autoimmune Toxicity and Loss of Tumor Response by Interleukin-17 Blockade
- (2017) Khashayar Esfahani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Opportunistic autoimmunity secondary to cancer immunotherapy (OASI): An emerging challenge
- (2017) M. Kostine et al. REVUE DE MEDECINE INTERNE
- Exacerbation of Psoriasis During Nivolumab Therapy for Metastatic Melanoma
- (2016) N Matsumura et al. ACTA DERMATO-VENEREOLOGICA
- Nivolumab-Induced Recurrence of Rheumatoid Arthritis in a Patient With Advanced Non–Small Cell Lung Cancer: A Case Report
- (2016) Konstantinos Syrigos et al. ANNALS OF INTERNAL MEDICINE
- The use of ipilimumab in patients with rheumatoid arthritis and metastatic melanoma
- (2016) B. Lee et al. ANNALS OF ONCOLOGY
- Vasculitic neuropathy induced by pembrolizumab
- (2016) F. Aya et al. ANNALS OF ONCOLOGY
- Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
- (2016) A. M. Menzies et al. ANNALS OF ONCOLOGY
- Checkpoint immunotherapy: good for cancer therapy, bad for rheumatic diseases
- (2016) Leonard Calabrese et al. ANNALS OF THE RHEUMATIC DISEASES
- Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn’s disease: a case report
- (2016) Marc Uemura et al. Journal of Hematology & Oncology
- Severe Psoriasis Flare After Anti-Programmed Death Ligand 1 (PD-L1) Therapy for Metastatic Non–Small Cell Lung Cancer (NSCLC)
- (2016) Puey Ling Chia et al. JOURNAL OF IMMUNOTHERAPY
- Successful Anti-PD-1 Antibody Treatment in a Metastatic Melanoma Patient With Known Severe Autoimmune Disease
- (2016) Lara V. Maul et al. JOURNAL OF IMMUNOTHERAPY
- Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial
- (2016) F Stephen Hodi et al. LANCET ONCOLOGY
- Exacerbation of myasthenia gravis in a patient with melanoma treated with pembrolizumab
- (2016) K. H. Vincent Lau et al. MUSCLE & NERVE
- Myasthenia gravis exacerbation associated with pembrolizumab
- (2016) Julia Zhu et al. MUSCLE & NERVE
- Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?
- (2016) Michiel van der Vlist et al. Nature Reviews Rheumatology
- Pembrolizumab (Keytruda)
- (2016) Gerry Kwok et al. Human Vaccines & Immunotherapeutics
- Chorioretinal Lesions in a Case of Melanoma-Associated Retinopathy Treated With Pembrolizumab
- (2016) Philipp Roberts et al. JAMA Ophthalmology
- Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
- (2016) Douglas B. Johnson et al. JAMA Oncology
- Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid
- (2016) Kristen M. Beck et al. Journal for ImmunoTherapy of Cancer
- Antitumor activity of nivolumab on hemodialysis after renal allograft rejection
- (2016) Michael Ong et al. Journal for ImmunoTherapy of Cancer
- Serological aggravation of autoimmune thyroid disease in two cases receiving nivolumab
- (2015) Tomohiko Narita et al. JOURNAL OF DERMATOLOGY
- Exacerbation of psoriasis vulgaris during nivolumab for oral mucosal melanoma
- (2015) Y. Kato et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy
- (2015) Jennifer A. Lo et al. JAMA Oncology
- Rapid complete response of metastatic melanoma in a patient undergoing ipilimumab immunotherapy in the setting of active ulcerative colitis
- (2015) A Doran Bostwick et al. Journal for ImmunoTherapy of Cancer
- Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma
- (2015) Ahmad A. Tarhini et al. Journal for ImmunoTherapy of Cancer
- Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune disease
- (2014) Magnus Pedersen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Ipilimumab in a patient with known Crohn's disease: To give or not to give?
- (2014) Eric A.R. Gielisse et al. Journal of Crohns & Colitis
- Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma
- (2014) Edward J Gettings et al. Multiple Sclerosis Journal
- Ipilimumab in patients with melanoma and autoimmune disease
- (2014) Chrisann Kyi et al. Journal for ImmunoTherapy of Cancer
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Updated assessment of the prevalence, spectrum and case definition of autoimmune disease
- (2012) Scott M. Hayter et al. AUTOIMMUNITY REVIEWS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now